IvelinRadkov/iStock via Getty Images
Avidity Biosciences (NASDAQ:RNA) has announced new data from its clinical trials evaluating the experimental treatment del-zota for Duchenne muscular dystrophy.
After one year of continuous treatment, participants showed not only a halt in disease progression, but also measurable improvements compared to their
Phillippe Laffont has built a reputation as one of the world's best tech investors. His hedge fund, Coatue Management, is...
Apr 04, 2026, 2:01 PM ETBP p.l.c. (BP) Stock, E Stock, XOM Stock, CVX StockCOP, SHEL, EONGY, ENLAY, ESOCF, ENGIY,...
The most closely watched U.S. economic indicators have turned upside down as President Donald Trump’s immigration crackdown sends the labor...
Apr 04, 2026, 1:07 PM ETCrude Oil Futures (CL1:COM), CO1:COM, XLE, USOUCO, DBO, UNG, FCG, USL, SCO, UNL, BNO, BOIL,...
Ongoing geopolitical tensions in the Middle East have sent the price of oil soaring, fueling fears of a slowdown in...
China is stepping up its diplomacy on the Iran war, putting forward a five-point proposal with Pakistan, rallying support from Gulf...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
